1 year follow Up results of “ARTIM HF TRIAL” (angiotensin receptor neprilysin inhibitor effect on TEI index & left ventricular mass in heart failure)

Background: Sacubitril/Valsartan (ARNI) has now class 1 recommendation for treatment of heart failure with reduced ejection fraction (HFrEF). It has been shown to reduce cardiovascular morbidity & mortality in Heart failure with reduced ejection fraction (HFrEF) and significant improvement i...

Full description

Bibliographic Details
Main Authors: Rajendra Kumar Gokhroo, Kaul Anushri, M.T. Tarik, C. Kailash, N. Rajesh, K. Ashish, G. Manish, C. Subhash
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Indian Heart Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483221000109